HBPCF (Helix BioPharma) Inventory Turnover : 0.00 (As of Jan. 2025)

View and export this data going back to 2008. Start your Free Trial

What is Helix BioPharma Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Helix BioPharma's Cost of Goods Sold for the three months ended in Jan. 2025 was $0.00 Mil. Helix BioPharma's Average Total Inventories for the quarter that ended in Jan. 2025 was $0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Helix BioPharma Inventory Turnover Historical Data

The historical data trend for Helix BioPharma's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Helix BioPharma Inventory Turnover Chart

Helix BioPharma Annual Data

Trend

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Jul24

Inventory Turnover

Get a 7-Day Free Trial

Helix BioPharma Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Inventory Turnover	Get a 7-Day Free Trial															-	-	-	-	-

Helix BioPharma Inventory Turnover Calculation

Helix BioPharma's Inventory Turnover for the fiscal year that ended in Jul. 2024 is calculated as

	Inventory Turnover (A: Jul. 2024 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Jul. 2024 )	/ (	(Total Inventories (A: Jul. 2023 )	+	Total Inventories (A: Jul. 2024 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Helix BioPharma's Inventory Turnover for the quarter that ended in Jan. 2025 is calculated as

	Inventory Turnover (Q: Jan. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Jan. 2025 )	/ (	(Total Inventories (Q: Oct. 2024 )	+	Total Inventories (Q: Jan. 2025 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Helix BioPharma (OTCPK:HBPCF) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Helix BioPharma's Days Inventory for the three months ended in Jan. 2025 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Jan. 2025 )	/	Cost of Goods Sold (Q: Jan. 2025 )	*	Days in Period
	=	0	/	0	*	365 / 4
	=

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Helix BioPharma's Inventory to Revenue for the quarter that ended in Jan. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Jan. 2025 )	/	Revenue (Q: Jan. 2025 )
	=	0	/	0
	=

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Helix BioPharma Inventory Turnover Related Terms

Thank you for viewing the detailed overview of Helix BioPharma's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Helix BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Helix BioPharma Corp (OTCPK:HBPCF) » Definitions » Inventory Turnover

Comparable Companies

Traded in Other Exchanges

HBP0:Germany HBP:Canada

Address

40 Temperance Street, Suite 2700, Bay Adelaide Centre - North Tower, Toronto, ON, CAN, M5H0B4

Website

https://www.helixbiopharma.com

Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidate is L-DOS47 for Tumor Defence Breaker is in clinical trials for pancreatic cancer.